v3.25.1
Cover
 12 Months Ended
Dec. 31, 2024
shares
Document Information [Line Items]  
Document Type 20-F
Document Registration Statement false
Document Annual Report true
Document Transition Report false
Document Financial Statement Error Correction [Flag] false
Document Shell Company Report false
Entity Interactive Data Current Yes
Document Accounting Standard U.S. GAAP
ICFR Auditor Attestation Flag false
Amendment Flag false
Document Period End Date Dec. 31, 2024
Document Fiscal Year Focus 2024
Document Fiscal Period Focus FY
Entity Information [Line Items]  
Entity Registrant Name Scinai Immunotherapeutics Ltd.
Entity Central Index Key 0001611747
Entity File Number 001-37353
Entity Incorporation, State or Country Code L3
Current Fiscal Year End Date --12-31
Entity Well-known Seasoned Issuer No
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Shell Company false
Entity Filer Category Non-accelerated Filer
Entity Emerging Growth Company false
Entity Incorporation, Date of Incorporation Jul. 21, 2003
Entity Contact Personnel [Line Items]  
Entity Address, Address Line One Jerusalem BioPark
Entity Address, Address Line Two 2nd floor
Entity Address, Address Line Three Hadassah Ein Kerem Campus
Entity Address, City or Town Jerusalem
Entity Address, Country IL
Entity Address, Postal Zip Code 00000
Entity Listings [Line Items]  
Title of 12(b) Security American Depositary Shares, each representing 4,000 ordinary share, no par value
Trading Symbol SCNI
Security Exchange Name NASDAQ
Entity Common Stock, Shares Outstanding 3,411,983,584
Business Contact [Member]  
Entity Contact Personnel [Line Items]  
Contact Personnel Name Amir Reichman
Entity Address, Address Line One Jerusalem BioPark
Entity Address, Address Line Two 2nd floor
Entity Address, Address Line Three Hadassah Ein Kerem Campus
Entity Address, City or Town Jerusalem
Entity Address, Country IL
Entity Address, Postal Zip Code 00000
Entity Phone Fax Numbers [Line Items]  
City Area Code (+972)
Local Phone Number 8-930-2529